D-galactose supplementation for the treatment of patients with mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE): An interim analysis of a proof-of-concept trial

Aledo-Serrano A, Toledano R, Garcia-Morales I, Budke M, Beltran-Corbellini A, Blumcke I, Coras R, Gil-Nagel A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Epilepsia Wiley-Blackwell

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 22-23

Conference Proceedings Title: EPILEPSIA

Authors with CRIS profile

Roland Coras Institute of Neuropathology

Involved external institutions

Ruber International Hospital ES Spain (ES)

How to cite

APA:

Aledo-Serrano, A., Toledano, R., Garcia-Morales, I., Budke, M., Beltran-Corbellini, A., Blumcke, I.,... Gil-Nagel, A. (2022). D-galactose supplementation for the treatment of patients with mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE): An interim analysis of a proof-of-concept trial. In EPILEPSIA (pp. 22-23). HOBOKEN: WILEY.

MLA:

Aledo-Serrano, A., et al. "D-galactose supplementation for the treatment of patients with mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE): An interim analysis of a proof-of-concept trial." Proceedings of the EPILEPSIA HOBOKEN: WILEY, 2022. 22-23.

BibTeX: Download